Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition

Authors not listed

Beth Israel Deaconess Medical Center · 2019

Abstract

The aim of this study is to explore the relationship between cortical hyperexcitability, abnormalities of brain network function, and cognitive dysfunction in human patients with AD and whether administration of the antiepileptic medication levetiracetam (LEV) normalizes these measures and improves cognition.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Anonymous. (2019). Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition. <em>Beth Israel Deaconess Medical Center</em>. https://clinicaltrials.gov/study/NCT03875638
Vancouver
Anonymous. Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition. Beth Israel Deaconess Medical Center. 2019.
BibTeX
@misc{anon2019Treati, title = {Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition}, author = {Anonymous}, journal = {Beth Israel Deaconess Medical Center}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings